Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 284,638 |
|
|||||
| News | - | ||||||
| Day High | 46.35 | Low High |
|||||
| Day Low | 45.40 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Vericel Corporation | VCEL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.33 | 0.73% | 45.78 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 45.66 | 45.40 | 46.35 | 46.05 | 45.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,313 | 284,638 | US$ 45.93 | US$ 13,072,649 | - | 29.70 - 53.05 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:33:35 | formt | 308 | US$ 45.78 | USD |
Vericel Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.22B | 48.29M | - | 197.52M | -3.18M | -0.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vericel News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VCEL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 43.67 | 47.14 | 42.375 | 45.19 | 328,589 | 2.11 | 4.83% |
| 1 Month | 52.60 | 53.05 | 42.375 | 48.39 | 346,739 | -6.82 | -12.97% |
| 3 Months | 43.01 | 53.05 | 41.58 | 47.13 | 435,976 | 2.77 | 6.44% |
| 6 Months | 34.55 | 53.05 | 32.28 | 41.24 | 468,088 | 11.23 | 32.50% |
| 1 Year | 29.70 | 53.05 | 29.70 | 38.29 | 405,743 | 16.08 | 54.14% |
| 3 Years | 60.25 | 68.94 | 17.30 | 36.70 | 426,459 | -14.47 | -24.02% |
| 5 Years | 17.60 | 68.94 | 6.78 | 30.47 | 504,902 | 28.18 | 160.11% |
Vericel Description
| Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases. |
